Cost of care distribution in atrial fibrillation patients: the COCAF study

Kannel, 1998, Prevalence, incidence, prognosis and predisposition for atrial fibrillation, Am J Cardiol, 82, 2N, 10.1016/S0002-9149(98)00583-9 Benjamin, 1998, Impact of atrial fibrillation on the risk of death, Circulation, 98, 946, 10.1161/01.CIR.98.10.946 Frost, 1999, Decrease in mortality in patients with an hospital diagnosis of atrial fibrillation in Denmark during the period 1980-1993, Eur Heart J, 20, 1592, 10.1053/euhj.1999.1713 Caisse Nationale d'Assurance Maladie des Travailleurs Salariés (CNAMTS). Carnets statistiques 1996 n°81. Le secteur libéral des professions de santé en 1995 Union des Caisses Nationales de Sécurité Sociale (UCANSS). Nomenclature générale des actes professionnels, 1998 Levy, 1999, Characterization of different subsets of atrial fibrillation in general practice in France, Circulation, 99, 3028, 10.1161/01.CIR.99.23.3028 Stewart, 2001, Trends in hospital activity, morbidity and case fatality related to atrial fibrillation in Scotland, 1986-1996, Eur Heart J, 22, 693, 10.1053/euhj.2000.2511 Gustafsson, 1992, Cost effectiveness of primary stroke prevention in atrial fibrillation, BMJ, 305, 1457, 10.1136/bmj.305.6867.1457 Ebrahim, 2000, Cost effectiveness of stroke prevention, Br Med Bull, 56, 557, 10.1258/0007142001903201 Wolf, 1998, Impact of atrial fibrillation on mortality, stroke and medical costs, Ann Intern Med, 158, 229, 10.1001/archinte.158.3.229 Thomson, 2000, Decision analysis and guidelines for anticoagulant therapy to prevent stroke in patients with atrial fibrillation, Lancet, 355, 956, 10.1016/S0140-6736(00)90012-6 Eckman, 1998, Cost effectiveness of therapy for patients with non valvular atrial fibrillation, Arch Intern Med, 158, 1669, 10.1001/archinte.158.15.1669 Gage, 1995, Cost effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with non valvular atrial fibrillation, JAMA, 274, 1839, 10.1001/jama.1995.03530230025025 Laupacis, 1998, Antithrombotic therapy in atrial fibrillation, Chest, 114, 579, 10.1378/chest.114.5_Supplement.579S 2002, A comparison of rate control and rhythm control in patients with atrial fibrillation, N Engl J Med, 347, 1825, 10.1056/NEJMoa021328 Catherwood, 1999, Cost effectiveness of cardioversion and antiarrhythmic therapy in non valvular atrial fibrillation, Ann Intern Med, 130, 625, 10.7326/0003-4819-130-8-199904200-00002 Simons, 1997, Cost effectiveness of inpatient initiation of antiarrhythmic therapy for supraventricular tachycardias, Am J Cardiol, 80, 1551, 10.1016/S0002-9149(97)00773-X Moeremans, 2000, Second line pharmacological management of paroxysmal and persistent atrial fibrillation in France, Value Health, 3, 407, 10.1046/j.1524-4733.2000.36001.x Dell'orfano, 1999, Acute treatment of atrial fibrillation, Am J Cardiol, 43, 788, 10.1016/S0002-9149(98)00993-X Naccarelli, 2000, Cost effective management of acute atrial fibrillation, Am J Cardiol, 85, 36, 10.1016/S0002-9149(00)00905-X Jensen, 1995, Long-term follow-up of patients treated by radiofrequency ablation of the atrio-ventricular junction, Pace, 18, 1609, 10.1111/j.1540-8159.1995.tb06982.x Björck Linne, 2000, Health care cost of heart failure, Eur J Heart Failure, 2, 291, 10.1016/S1388-9842(00)00089-1 ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. Eur Heart J 2001;22:1852–1923